epileptic foci I and the persisting anticonvulsant activity of anaesthetics such as thiopentone and its metabolite pentobarbitone. 1 A prospective anaesthetic audit at The Amalgamated Melbourne and Essendon Hospitals during the period January 1981 to June 1986 reported that three patients had generalised seizures in the recovery room following neurosurgery. However, in the subsequent eighteen months, six neurosurgical patients were reported to have had seizures in the recovery room. This appeared to coincide with the introduction of isoflurane and the administration of large doses of atracurium by infusion during neurosurgery. Table 1 details the incidence of recovery room seizures during 1985-87 in neurosurgical patients according to the anaesthetic drugs administered. The case histories of the five patients administered atracurium and isoflurane who had unexplained seizures are presented below. One of the patients having seizures, who did not receive either atracurium or isoflurane, had surgery for excision of an epileptogenic focus with poorly controlled seizures preoperatively. Postoperative seizures are increased two to four times if seizures occur prior to surgery.3.4
Case Reports
Case 1: An 18-year-old, 68 kg male underwent a left frontal craniotomy and anterior dural repair for cerebrospinal fluid rhinorrhea following a left frontal compound fracture. At that time he had been commenced on prophylactic oral phenytoin 300 mg daily. Anaesthesia was induced with thiopentone 600 mg and atracurium 40 mg and maintained with a continuous infusion of thiopentone and isoflurane 0.5%. An atracurium infusion was adjusted to maintain a post-tetanic count of one, with a maintenance rate of 15 Ilg.kg.-Imin-I. The procedure lasted 240 minutes during which the patient received total doses of atracurium 210 mg, thiopentone 2 g, amoxycillin 2 g, flucloxacillin 2 g, frusemide 20 mg and phenytoin 300 mg.
On arrival in the recovery room, the patient was drowsy with normal arterial blood gases and serum electrolytes. Sixty minutes later he had recurrent grand mal seizures. These were poorly controlled despite further anticonvulsants and he was reintubated and ventilated. Seizures ceased after four hours. A cerebral computed tomography (CT) scan showed evidence of frontal lobe oedema. He was extubated the following day and discharged on the tenth postoperative day with no further seizures. No other patient who had a thiopentone infusion during neurosurgery has had a seizure in the recovery Anaesthesia and Intensive Care. Vol. 17. No. 4. November. 1989 room at our institution.
Case 2: A 57-year-old, 70 kg male had a frontal craniotomy for excision of an astrocytoma after presenting with increasing bifrontal headaches. Preoperatively he received phenytoin 300 mg and dexamethasone 16 mg p.o. daily. Anaesthesia was induced with thiopentone 475 mg, fentanyl 100 Ilg, atracurium 35 mg and was maintained with isoflurane 0.5% in nitrous oxide and oxygen. Atracurium was infused at a rate of 13 Ilg.kg. -I min-I. In an uneventful procedure lasting 225 minutes, the patient received total doses of atracurium 213 mg, thiopentone 475 mg, fentanyl 275 Ilg, amoxycillin 1.5 g, flucloxacillin 1.5 g and phenytoin 400 mg.
Fifteen minutes after arrival in the recovery room the patient had a grand mal seizure which was treated with phenytoin and phenobarbitone. Arterial blood gases immediately before and after the seizure were normal. The patient had no further seizures and was discharged on the tenth postoperative day.
Case 3: A 67-year-old, 76 kg man had a craniotomy for excision of a right anterior cranial fossa meningioma. Phenytoin 300 mg and dexamethasone 16 mg p.o. daily had been commenced prior to admission. Anaesthesia was induced with thiopentone 250 mg, fentanyl 100 Ilg, and atracurium 40 mg and maintained with isoflurane 0.5-1 % in nitrous oxide and oxygen. Atracurium was infused at a rate of 13 Ilg.kg. -I min-I. The tumor resection, taking 450 minutes, was uneventful. The patient received total doses of atracurium 435 mg, thiopentone 300 mg, fentanyl 100 Ilg, amoxycillin 1.0 g, flucloxacillin 1.0 g, frusemide 10 mg, phenytoin 200 mg and dexamethasone 16 mg.
In the recovery room, the patient was conscious with normal arterial blood gases and serum electrolytes, but after fourteen minutes had recurrent grand mal seizures. He was reintubated, ventilated and treated with diazepam, phenytoin and phenobarbitone. However, seizures persisted for five hours and were eventually controlled with a thiopentone infusion. A postoperative cerebral CT scan showed a slight increase in frontal lobe oedema compared with a preoperative scan. He was discharged on the 22nd postoperative day after making a slow recovery, with no further seizures.
Case 4: An 85-year-old, 49 kg woman underwent a bifrontal craniotomy for excision of a falcine meningioma, after presenting with mental deterioration. One week prior to surgery she was commenced on phenytoin 300 mg and dexamthasone 16 mg p.o. daily. Anaesthesia was induced with thiopentone 200 mg, fentanyl 1 00 ~g and atracurium 35 mg and maintained with isoflurane 0.5-1 % in nitrous oxide and oxygen. Atracurium was infused at a rate of 13 ~g.kg.-lmin-l. In an uneventful procedure lasting 300 minutes the patient received total doses ofatracurium 235 mg, thiopentone 400 mg, fentanyl 1 00 ~g, amoxycillin 2g, flucloxacillin 2 g, frusemide 20 mg, phenytoin 200 mg and dexamethasone 12 mg.
The patient was drowsy on arrival in the recovery room. Arterial blood gases and serum electolytes were normal. Forty-five minutes later she had a grand mal seizure which was treated with phenytoin and phenobarbitone. Repeat arterial blood gases were normal. The arterial serum laudanosine concentration soon after the seizure was 0.26 ~g/ml. One further seizure occurred the following day. She made a good recovery and was discharged on the 15th postoperative day.
Case 5: A 72-year-old, 65 kg woman was admitted for elective clipping of a right posterior communicating artery aneurysm following a subarachnoid hemorrhage five months previously. On admission she was disorientated and confused. Daily medication included phenytoin 300 mg, dexamethasone 16 mg, atenolol 50 mg and nifedipine 30 mg. Anaesthesia was induced with thiopentone 300 mg, lignocaine 100 mg, fentanyl 1 00 ~g and atracurium 25 mg and maintained with isoflurane 0.5-1 % in nitrous oxide and oxygen. Atracurium was infused at 12 ~g.kg.-lmin-l. The aneurysm was clipped in a procedure lasting 150 minutes. Intraoperatively the blood pressure was labile and was controlled with a trimetaphan infusion and incremental doses of atenolol. She received total doses of atracurium 130 mg, thiopentone 400 mg, fentanyl 1 00 ~g, amoxycillin 1.0 g, flucloxacillin 1.0 g, mannitol 40 g and dexamethasone 12 mg during the procedure.
On arrival in the recovery room the patient was drowsy with an arterial blood pressure of 200/120 mmHg. Arterial blood gases and electolytes were normal. Five minutes later she had a grand mal seizure followed by a second seizure fifty minutes later. The seizures were controlled with diazepam, phenytoin and phenobarbitone. A cerebral CT scan showed no significant change from a previous study. She remained intermittently hypertensive but with no further seizures, and was discharged on the 25th postoperative day.
DISCUSSION
After neurosurgery, patients are prone to seizures arising from local cortical injury due to cortical tissue resection or significant retraction. 4 ,5 However, this alone does not explain the observed increased incidence of recovery room seizures during the latter half of 1986 and 1987 as there was no significant change in the type and frequency of neurosurical procedures. Additional precipitating factors which should be considered include hypoxia, hypocarbia, hypoglycaemia, hyponatraemia, and pyrexia. 5 The patients in this report had normal arterial blood gases, electrolytes and random blood sugars. Another factor is the administration of drugs with epileptogenic potential. Neurosurgical patients are uniquely susceptible to epileptogenic effects of drugs as evidenced by a report of early seizures in three of eight neurosurgical patients administered methohexitone by infusion. 6 Of the drugs given to these patients, atracurium may have an epileptogenic potential in man due to its principal metabolite laudanosine. 7 This alkaloid has been shown to induce epileptiform activity on the electroencephalogram (EEG) in healthy rabbits at a plasma concentration of 5 ~g/ml, 8 and dogs at 1 7 ~g/mV whereas concentrations of up to 1 00 ~g/ml do not induce epileptiform activity in cats. iO This large species-dependent effect makes it impossible to make quantitative extrapolations to man. There is no data on the potential laudanosine has to cause seizures in man, but it has been shown to cross the blood-brain barrier and is detectable in the CSF.II A possible synergistic role for laudanosine in seizures following enflurane anaesthesia has been suggested. 12 Atracurium has previously been reported to be safe in neurosurgical procedures with no case of early seizures, including forty patients in whom it was administered in conjunction with isoflurane. 13 -16 However, atracurium, administered with isoflurane, is implicated in this case report by a statistical association with an increase in incidence of early seizures as detailed in Table 1. A major difference between these case reports and previous published reports of atracurium during neurosurgery is the dose administered. Tbese patients received large doses of atracurium, infused at a rate of 12-15 Ilg.kg.-imin-i to maintain a post-tetanic count of one. 17 This was used to prevent any sudden movement including coughing. 18 In contrast, the previous published reports in neurosurgery used lower doses of atracurium, with infusion rates of 8 Ilg.kg.-imin-i or small incremental doses.1 3 -1 6 Laudanosine has a relatively long elimination half-life and tends to accumulate during infusion of atracurium. 19 In one patient a post-seizure arterial laudanosine concentration was 0.26 Ilg/ml one hour after cessation of the atracurium infusion. This plasma level is similar to the peak plasma laudanosine concentration following a single 0.5 mg/kg dose of atracurium. 20 However, laudanosine is highly lipophilic and tends to be se quested in the CNS in which it has a large distribution volume. II The patient effectively received a large dose oflaudanosine and would have had a relatively high CNS laudanosine concentration. Low CNS laudanosine and low CSF concentrations (2-13 ng/ml) occur following a single bolus dose of atracurium. II Isoflurane is another drug given to these patients which may have epileptogenic potential in man. Clinical case reports have suggested that isoflurane may be a rare cause of seizure-like activity in otherwise normal patients. 21 ,22 The commonly used ether anaesthetics exhibit a dose-related epileptogenicity, their mInImUm epileptogenic concentrations (MECs) appearing to be a function of the number, type and distribution of halogen atoms in the anaesthetic molecule. 23 • 24 At low doses, up to 1.0 MAC, the EEG effects of isoflurane are similar to those of enflurane, but at greater than 2 MAC, isoflurane causes progressive EEG suppression leading to electrical silence. 25 In some individuals isoflurane may have stimulatory rather than depressant effects on the EEG. 26 In this case report, isoflurane is implicated by its association with an increase in the incidence of seizures ( Table  1 ). The data suggests that isoflurane and atracurium have a synergistic effect as no patient having 'high' dose atracurium alone had seizures. In contrast, animal studies suggest that isoflurane, at an end-tidal concentration of 1.6%, increases the seizure threshold for laudanosine_ 8 It is difficult to extrapolate this finding to this report as it may be both a species-specific and/or a concentration-dependent effect.
Other drugs with epileptogenic potential administered to these patients include fentanyl, penicillin-derived antibiotics, and nitrous oxide. Nitrous oxide, which was administered to four of the five patients in this case report, has been shown to decrease the seizure threshold for laudanosine in rabbits at an end-tidal concentration of 70%.8 However, its role in precipitating seizures up to 45 minutes following surgery is uncertain.
Inadequate anticonvulsant therapy may also have been a factor in these seizures. The plasma level of phenytoin may have been low as the pharmacokinetics of phenytoin are variable, although this is less likely in four of the five cases reported as phenytoin had been administered for more than one week. 27, 28 Neurosurgical and neuroanaesthetic practice had not changed over this three year period apart from the introduction of isoflurane and the administration of higher doses of atracurium. It is unlikely therefore that these other factors are the primary cause of the observed increased incidence of recovery room seizures.
In conclusion, we believe that these reports of seizures in the recovery room following neurosurgery represent a significant deviation from our previous experience and show the benefit of an ongoing anaesthetic audit. The individual contributions of atracurium when administered in high dose, via its metabolite laudanosine, and of isoflurane are impossible to determine and must remain a matter of conjecture. However this report suggests that their administration together may be associated with a slight increase in the incidence of early seizures in patients following neurosurgery.
